Karissa Waddick
EditorKarissa Waddick is an editor for PharmaVoice. She most recently covered the ins and outs of workplace safety and health policy for Inside Washington Publishers, writing about federal and local COVID-19 vaccine regulations. Prior to that role, she helped build a database of need-to-know policy and business influencer profiles at National Journal. Though a Boston-area native, Karissa moved to the Washington, D.C., area to attend American University and has stayed ever since. She is an avid Red Sox fan, amateur photographer and crafting enthusiast.
93 articles by Karissa Waddick
-
3 FDA decisions that could be delayed if the U.S. defaults on its debt
May 30, 2023 -
Strangers in a strange land: 8 unlikely companies making plays in pharma
May 22, 2023 -
Biden’s pick to lead the NIH faces an uphill battle
May 18, 2023 -
Major regulatory changes are coming to pharma in the EU — and industry’s weighing in
May 16, 2023 -
How pharma’s rocky real estate market has changed — for better and worse
May 11, 2023 -
Insulin prices have dropped — will Civica still be a disrupter in the field?
May 8, 2023 -
Navigating workforce challenges amid a turbulent biopharma market
May 4, 2023 -
BMS’s CEO transition will be a major test for the pharma giant
April 28, 2023 -
Roy Vagelos is retiring and leaving a legacy of leadership lessons
April 25, 2023 -
20 years on, the next stage of the human genome revolution is brewing
April 24, 2023 -
Patient influencers are here to stay — where are the regulations?
April 17, 2023 -
What’s pharma doing wrong to improve trial diversity? ‘Everything’
April 12, 2023 -
A drug just launched for a disease discovered only 10 years ago
April 6, 2023 -
Staff shortages cause slowdowns in booming cell and gene therapy market
April 3, 2023 -
Predator and prey: Harnessing phages to fight antibiotic resistance
March 30, 2023 -
Cutting the cord — why streaming is a new frontier for pharma advertising
March 27, 2023 -
Everyone says they’re patient-centric, but have they really walked the walk?
March 23, 2023 -
This biotech’s ‘Microsoft’ approach could change how we see gene therapy
March 20, 2023 -
In the fallout from Aduhelm, Biogen’s leadership shakeup continues
March 16, 2023 -
Biden doubles down on drug pricing in 2024 budget — but boosts R&D
March 13, 2023 -
While many leverage precision medicine, Faeth is banking on precision nutrition to tackle cancer
March 9, 2023 -
FDA ups generics and biosimilar approvals for a shot at lower drug costs
March 6, 2023 -
PharmaVoice 100 honorees: Where are they now?
March 3, 2023 -
Reata’s stock plummets amid sudden FDA neuro office shakeup
Feb. 28, 2023 -
Who is Vivek Ramaswamy — the biotech entrepreneur turned presidential candidate?
Feb. 27, 2023